Research & Education

Radiotherapy’s role in malignant airway obstruction

Latest in November issue of Journal of Thoracic Oncology

DENVER – Malignant airway obstruction is a common cause of ICU admission, often because of lung cancers, lymphoma or other thoracic malignancies. Severe cases are life threatening, and although therapeutic bronchoscopic intervention may assist in restoring airway patency and facilitating extubation, many patients are ineligible for such intervention. For patients requiring intubation and mechanical ventilation because of malignant airway obstruction, the efficacy of radiotherapy for achieving extubation is unknown. Although external beam radiotherapy is a cornerstone of treatment for lung cancer, the use of it in intubated patients is uncertain.

Researchers believe arsenic-induced lung tumors caused by different molecular mechanisms than common lung cancer

Latest in November issue of Journal of Thoracic Oncology


IASLC Names Fred R. Hirsch, MD, PhD as New CEO

Dr. Hirsch will replace Dr. Paul A. Bunn, Jr. after World Conference in 2013

The International Association for the Study of Lung Cancer (IASLC) Board of Directors has selected Fred R.

Accelerated radiotherapy more efficient than current practice

Latest study recommends accelerated radiotherapy for un-resected NSCLC patients

DENVER – Radiotherapy with or without chemotherapy is increasingly being used in the curative treatment for un-resected non-small cell lung cancer

Researchers study survival in African American versus Caucasian lung cancer patients

Study finds that no racial difference of people of same socioeconomic status

DENVER – According to the American Cancer Society, an estimated 160,340 lung cancer deaths occurred in the United States in 2012, accounting for 28

Chemotherapy helps elderly patients with small cell lung cancer

Treatment associated with 6-month improvement, even in patients older than 80

DENVER – Although numerous randomized clinical trials have demonstrated a benefit of chemotherapy for patients with small-cell lung cancer (SCLC),